Dense CRISPR Mapping of the WAVE Complex Identifies Pharmacological Modulators of AD-Linked Myeloid Migration
Preprint
Abstract
Although genetic risk for Alzheimer’s disease (AD) strongly converges on microglial pathways, the druggable functional protein regions that control disease-relevant microglial behaviors remain largely unknown. Here, we applied dense CRISPR-Cas9 mutagenesis and CRISPRtile-based functional mapping to the WAVE regulatory complex (WRC), a central regulator of actin remodeling and cell migration. In a pooled CCL2-directed migration assay in human THP-1 myeloid cells, perturbation of NCKAP1L , CYFIP1 , and BRK1 impaired migration and revealed divergent effects among WRC paralogs. Residue-level analysis mapped discrete migration-associated functional regions within CYFIP1 and NCKAP1L, including a CYFIP1 regulatory hotspot and a prioritized NCKAP1L region nominated for pharmacological targeting. Human single-nucleus datasets identified NCKAP1L as a microglia-enriched WRC component expressed across diverse microglial states. Machine-learning-guided compound prediction nominated Montelukast sodium and Piperacetazine, which we experimentally validated as negative and positive modulators of chemokine-directed migration, respectively. These findings establish WRC-dependent migration as a pharmacologically tunable myeloid process relevant to AD.Keywords
Funding Information
- National Institute on Aging (R01AG070118)
This publication has 58 references indexed in Scilit:
- Alzheimer’s disease risk protein SorLA regulates ER homeostasis and lipid metabolism in human microglia, with conserved effects in neuronsActa Neuropathologica, 2026
- The evolving landscape of Alzheimer’s disease therapy: From Aβ to tauCell, 2025
- 2025 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2025
- Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunctionActa Neuropathologica, 2024
- Epigenomic dissection of Alzheimer’s disease pinpoints causal variants and reveals epigenome erosionCell, 2023
- Human microglial state dynamics in Alzheimer’s disease progressionCell, 2023
- HEM1 Actin Immunodysregulatory Disorder: Genotypes, Phenotypes, and Future DirectionsJournal of Clinical Immunology, 2022
- Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic TrialsNeurotherapeutics, 2022
- MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics TrajectoriesBiophysical Journal, 2015
- Environment and exposure to solvent of protein atoms. Lysozyme and insulinJournal of Molecular Biology, 1973